UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT
Pursuant To Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): June 27, 2006
|
|
|
|
|
|
ANGIODYNAMICS, INC. |
|
|
|
|
|
|
|
(Exact Name of Registrant as Specified in its Charter) |
|
|
|
|
|
|
|
Delaware |
|
|
|
|
|
|
|
(State or Other Jurisdiction of Incorporation) |
|
|
|
|
|
|
|
|
|
0-50761 |
|
11-3146460 |
|
|
|
|
|
|
|
|
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
|
|
603 Queensbury Avenue, Queensbury, New York |
|
12804 |
|
|
|
|
|
|
|
|
|
(Address of Principal Executive Offices) |
|
(Zip Code) |
|
|
|
|
|
|
|
(518) 798-1215 |
|
|
|
|
|
|
|
(Registrant’s telephone number, including area code) |
|
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions.
|
o |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
|
o |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
|
o |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
|
o |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. Other Events
|
|
1) |
On June 27, 2006, AngioDynamics, Inc. (“AngioDynamics”) issued a press release announcing a delay in its litigation matter with Diomed Inc., a copy of which is filed as Exhibit 99.1 to this report and which is incorporated herein by reference. |
|
Item 9.01 |
Financial Statements and Exhibits |
| |||
|
|
(d) |
Exhibit |
| ||
|
|
99.1 |
Press release dated June 27, 2006. | |||
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
Date: June 27, 2006 |
ANGIODYNAMICS, INC. |
(Registrant)
By: /s/ Eamonn P. Hobbs
Eamonn P. Hobbs
President, Chief Executive Officer
3
EXHIBIT INDEX
Exhibit
4